GeoVax Labs (GOVX) Financials

$0.47

$-0.02 (-3.13%)

As on 08-Sep-2026 16:01EDT

Market cap

$3 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	2.49	3.95	--	0.08	0.39
Cost of Revenue	8.96	18.12	0.10	20.72	0.06	15.55
Gross Profit	-8.96	-15.63	3.86	-20.72	0.08	0.39
Operating Expenses	11.58	6.01	29.00	6.02	14.11	19.13
Operating Profit (EBIT)	-20.53	-21.64	-25.14	-26.74	-14.03	-18.75
Other Income	--	--	--	--	--	--
Profit before Tax	-20.43	-21.46	-24.99	-25.97	-14.02	-18.57
Provision for Tax	--	--	--	0.00	-0.01	-0.04
Profit after Tax (Net Income)	-20.43	-21.46	-24.99	-25.97	-14.01	-18.53
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-14.02	-18.57

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1.76	3.83	5.05	5.76	26.60	4.36
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.17	0.58	--	--	1.75	2.00
Current Liabilities	2.71	1.94	3.11	3.52	4.75	5.44
Total Liabilities	7.36	6.34	8.16	9.28	31.35	11.80

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.47	1.03	0.22	1.40	2.41	0.17
Current Assets	4.18	5.31	7.93	7.89	28.94	11.63
Total Assets	7.36	6.34	8.16	9.28	31.35	11.80
Total Debt*	0.32	0.84	--	--	--	--
Net Current Assets	1.46	3.38	4.83	4.37	24.19	6.19

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-21.47	-24.68	-25.17	-19.03	-11.20
Cash Flow from Investing Activities	--	-0.03	-0.02	-0.05	-0.13	-0.05
Cash from Financing Activities	--	19.08	23.75	4.06	35.35	12.78
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-13.93	-12.39	-2.37	-14.29	-7.98	-43.46
Cash EPS ($)	--	-12.35	-2.36	-14.25	-7.95	-43.37
Adjusted Book Value ($)	--	2.21	0.48	3.17	15.15	10.23
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-12.40	-2.34	-13.85	-10.84	-26.26
Free Cash Flow per Share ($)	--	-12.41	-2.34	-13.88	-10.92	-26.37

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-441.81	-462.31	-160.47	-90.53	-262.32
ROE (%)	-731.34	-483.79	-462.31	-160.47	-90.53	-266.05
ROA (%)	-268.15	-296.11	-286.62	-127.82	-64.96	-167.02
EBIT Margin (%)	--	-862.34	-631.44	--	-17,319.75	-4,869.09
Net Margin (%)	--	-862.34	-631.98	--	-17,301.93	-4,813.37
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	-0.37	--	-1.00	-0.79	-0.79
EBIT Growth (%)	35.37	14.04	3.84	-85.09	25.16	-565.46
Net Profit Growth (%)	17.66	14.11	3.75	-85.28	24.37	-530.68
EPS Growth (%)	-28.01	-4.22	0.83	-0.79	0.82	-0.37
Book Value Growth (%)	-91.60	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.01	-1.04	-0.03	-0.08	-0.08
Price / Book Value	1.75	0.08	5.16	0.11	0.04	0.35
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	15.26	0.09	221,378.60	0.22	1.90	0.53
Close Price ($)	1.27	4.28	61.75	135.38	236.33	1,357.50
High Price ($)	107.88	67.75	279.50	521.25	1,612.50	3,266.25
Low Price ($)	0.96	2.88	27.25	112.50	199.13	1,215.00
Market Cap ($ Cr)	2.52	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.22	--	--	--	--
Short term debt to equity ratio	0.09	0.07	--	--	--	--
Current Ratio	1.54	2.74	2.55	2.24	6.10	2.14
Quick Ratio	1.54	--	--	--	--	2.15
Interest Coverage	--	--	-1,168.23	--	-246.79	-14,576.98

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	16.67	--	--	12.73
Asset Turnover	--	0.34	0.45	--	0.00	0.03
Receivable days	--	96.76	60.90	--	220.98	109.89
Inventory Days	--	--	--	--	-318.02	-2.72
Payable days	--	26.61	8,909.71	40.11	12,346.80	27.30
Cash Conversion Cycle	--	--	--	--	-12,443.84	79.87

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.